Navigation Links
Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Postherpetic Neuralgia
Date:9/19/2011

ve seen in our earlier clinical and pre-clinical studies."

Dr Milton Raff (Christiaan Barnard Memorial Hospital, Cape Town, South Africa), Principal Investigator for the Study, said: "Current treatments for postherpetic neuralgia are effective in some patients but a significant proportion either don't respond to therapy and are left with debilitating symptoms or suffer significant side effects. EMA401 offers an entirely novel approach to the treatment of the condition and could represent a valuable new option in an area where there is a clear need for new medicines."

In addition to PHN, Spinifex's clinical program for EMA401 will include studies in other neuropathic pain indications including pain and hypersensitivity in peripheral nerve injury patients, and pain and hypersensitivity in cancer chemotherapy patients. The market for neuropathic pain treatments is expected to continue to increase and is projected to reach US$6.2 billion by 2017. Despite this growth, current therapy needs to be improved as a significant proportion of neuropathic pain patients don't respond to current therapy and these treatments have dose-limiting side effects. As a result, EMA401 is being developed as a potential first-in-class oral treatment for neuropathic pain and related symptoms without central nervous system side effects.

Spinifex Pharmaceuticals

Spinifex Pharmaceuticals is an Australian biotechnology company developing new drug candidates for the treatment and management of pain.

Established in 2005 and based in Melbourne, Spinifex has applied its world-class drug development capabilities to advance product candidates. Its lead product EMA401 is under development as a potential first-in-class oral treatment for neuropathic pain and related symptoms without CNS side effects. Spinifex's Phase 2 program for EMA401 will include clinical trials in a number of neuropathic pain conditions. Spinifex investors are GBS Venture Partners, Brandon Capi
'/>"/>

SOURCE Spiniflex
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , February 27, 2015 ... bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz (CHF) in ...     ... ein neuartiges Herzüberwachungssystem für Patienten mit kongestiver ... dass sie ein Finanzierungsvorhaben über 5 Mio. ...
(Date:2/26/2015)... Calif. , Feb. 27, 2015  Finesse expands office ... Finesse Solutions announced the expansion of its operations ... is planned for mid-March and access for customers is ... the A-563, and located adjacent to the current office, ... the Finesse automation engineering team and allow Finesse to bring ...
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... quarter and full year 2014 financial results after the market ... with the release, the Company will host a conference call ... on Thursday, March 5, 2015 to discuss ... Interested parties may access the live conference call via ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2New Finesse Office in United Kingdom 2IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
... Oct. 8 Vical Incorporated (Nasdaq: VICL ... nonclinical data,demonstrating that the company,s Vaxfectin(R) adjuvant may ... vaccines and,peptide-based cancer vaccines. Alain P. Rolland, Pharm.D., ... present the data today,Wednesday, October 8, at the ...
... detecting polyps that can be ... missed during colonoscopy, ... of,Gastroenterology Annual Scientific Meeting in Orlando (ACG 2008), renowned,gastroenterologist Douglas ... evaluated the efficacy of the Third,Eye(R) Retroscope(R), a new device ...
Cached Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5
(Date:2/27/2015)... Jacksonville, FL (PRWEB) February 27, 2015 ... to as “cutters”, are often misunderstood, misdiagnosed ... to return to healthy lives. Jacksonville-based ... the doors of its highly acclaimed Lakeview ... and others interested in understanding this complicated ...
(Date:2/27/2015)... 2015 Clinovo, a leading provider of ... Data Capture (EDC) at the CALBIO2015 conference ... and March 3rd at Booth # 141. , ... CRF and edit-check builder allowing Clinical Trials Managers to ... days, without any programming experience. Clinovo’s new pricing model ...
(Date:2/27/2015)... Pipette.com announces their limited time pricing ... only valid until the end of March 2015. The ... vortex mixer that allows for absolute control and true ... and is headquartered in Bohemia, New York. Scientific Industries ... as other rockers, incubators, and hybridization ovens which are ...
(Date:2/27/2015)... SACRAMENTO, Calif. (PRWEB) February 27, 2015 ... those who are documented to use Medicaid, the ... and families, according to a new study from ... that the greatest predictor of farmworker use of ... emergency care regardless of documentation status, was having ...
(Date:2/27/2015)... ME (PRWEB) February 27, 2015 Royal River ... ME, reports a new study that found adults who got ... develop type 2 diabetes compared to those who got the ... blood sugar levels. , The report is part of the ... ,” which Royal River Natural Foods publishes free each month ...
Breaking Medicine News(10 mins):Health News:Lakeview Health to Host Important Workshop Tackling the Rising Issue of ‘Cutters’ on March 27 2Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 2Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 3Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2
... University School of Medicine (BUSM) have found that yoga ... its positive effect on mood and anxiety. The findings, ... and Complementary Medicine , is the first to demonstrate ... decreased anxiety. The researchers set out to contrast ...
... care early in the treatment of patients with advanced ... of life, it also extended their lives. In ... , Massachusetts General Hospital (MGH) investigators report that patients ... palliative care along with standard treatment lived more than ...
... Reporter , WEDNESDAY, Aug. 18 (HealthDay News) -- Although it,s ... to produce any insulin after they,ve had the disease for ... destroyed by type 1 diabetes may actually be in a ... for decades. , This new research stems from a ...
... herbs in use for more than 1,800 years reduced ... actually enhancing the effects of the cancer treatment, Yale ... experiment consists of four herbs, called PHY906, and is ... used historically to treat nausea, vomiting and diarrhea. The ...
... Goodwin HealthDay Reporter , WEDNESDAY, Aug. 18 (HealthDay ... cigarettes have emerged as one of the most controversial products ... to them, with nearly 45 percent of smokers aged 12 ... Survey on Drug Use and Health. Most black teenaged smokers ...
... infectious disease experts at Rush University Medical Center are testing ... West Nile fever or suspected central nervous system infection due ... site in the Midwest enrolling patients into the $50 million ... The new drug treatment for West Nile virus that is ...
Cached Medicine News:Health News:Lung cancer patients receiving palliative care had improved quality of life, extended survival 2Health News:Lung cancer patients receiving palliative care had improved quality of life, extended survival 3Health News:Long-Term Type 1 Diabetes 'Survivors' Give Clues to the Disease 2Health News:Long-Term Type 1 Diabetes 'Survivors' Give Clues to the Disease 3Health News:FDA Mulling Ban on Menthol Cigarettes 2Health News:FDA Mulling Ban on Menthol Cigarettes 3Health News:FDA Mulling Ban on Menthol Cigarettes 4Health News:Study to examine new treatment for West Nile virus 2
Console Horizontal Airflow Cabinet...
... chemical fumes, allowing safe indoor ... filters remove most organic contaminants. ... flow speed = 100 fpm ... air speed monitor, quick-release filter/blower ...
... fume hood ventilates and purifies ... release of exhaust. Bonded charcoal ... Configurations are available with vertical ... final HEPA filter, work bench ...
... polypropylene exhaust hoods are designed to rest ... draw a stream of air across the ... operator. Other sizes and types of hoods ... are available on special order in materials ...
Medicine Products: